F
Francisco Robert
Researcher at University of Alabama
Publications - 7
Citations - 1075
Francisco Robert is an academic researcher from University of Alabama. The author has contributed to research in topics: Lung cancer & Receptor tyrosine kinase. The author has an hindex of 3, co-authored 7 publications receiving 1005 citations.
Papers
More filters
Journal ArticleDOI
Non–Small Cell Lung Cancer
David S. Ettinger,Wallace Akerley,Gerold Bepler,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Steven J. Feigenberg,Robert A. Figlin,Ramaswamy Govindan,Frederic W. Grannis,Thierry Jahan,Mohammad Jahanzeb,Anne Kessinger,Ritsuko Komaki,Mark G. Kris,Corey J. Langer,Quynh-Thu Le,Renato G. Martins,Gregory A. Otterson,Jyoti D. Patel,Francisco Robert,David J. Sugarbaker,Douglas E. Wood +24 more
TL;DR: In 2010, approximately 222,520 new cases of lung or bronchial cancer will be diagnosed in the USA, and 157,300 patients are expected to die of this disease as discussed by the authors.
Journal ArticleDOI
Small cell lung cancer.
Gregory P. Kalemkerian,Wallace Akerley,Robert J. Downey,David S. Ettinger,Frank V. Fossella,John C. Grecula,Thierry Jahan,Bruce E. Johnson,Anne Kessinger,Marianna Koczywas,Corey J. Langer,Renato G. Martins,Harvey B. Niell,Charles C. Pan,Nithya Ramnath,Neal Ready,Francisco Robert,Charles C. Williams +17 more
TL;DR: In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare, and smoking cessation should be strongly promoted.
Patent
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
TL;DR: In this article, a method to inhibit the growth of tumors in human patients, comprising treating the human patients with an effective amount of a combination of radiation and a non-radiolabeled protein receptor tyrosine kinase inhibitor, was proposed.
Journal ArticleDOI
B1-06: Multicenter, randomized study of Docetaxel versus Docetaxel plus Oblimersen in patients previously treated for non-small cell lung cancer (NSCLC)
Roy S. Herbst,Rafat Ansari,V Gorbunova,G Manikhas,Mansoor N. Saleh,Thomas E. Boyd,Christopher G. Azzoli,Francisco Robert,Loretta M. Itri,Robert Chapman +9 more